ES2178352T3 - Derivados de omega-cicloaquil-prostaglandina e1. - Google Patents

Derivados de omega-cicloaquil-prostaglandina e1.

Info

Publication number
ES2178352T3
ES2178352T3 ES99305735T ES99305735T ES2178352T3 ES 2178352 T3 ES2178352 T3 ES 2178352T3 ES 99305735 T ES99305735 T ES 99305735T ES 99305735 T ES99305735 T ES 99305735T ES 2178352 T3 ES2178352 T3 ES 2178352T3
Authority
ES
Spain
Prior art keywords
sub
derivatives
omega
cicloaquil
prostaglandina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99305735T
Other languages
English (en)
Inventor
Shuichi Ohuchida
Kousuke Tani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2178352T3 publication Critical patent/ES2178352T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se presentan derivados de la omega-cicloalquil-prostaglandina E1 de la fórmula (1) en donde R¿sup,1} es OH, etc; X es Cl, F; R{sup,2} es H, alquilo C{sub,1-8}, alquenilo C{sub,2-8}, alquinilo C{sub,2-8} que puede estar sustituido; n es 0-4, las sales no tóxicas de los mismos o los clatratos de ciclodextrina de los mismos pueden unirse fuertemente sobre el receptor de subtipo EP{sub,2}. Por lo tanto, los derivados son útiles para la prevención y/o tratamiento de disfunciones inmunológicas (enfermedades autoinmunes, rechazos de miembros trasplantados, etc), el asma, la formación anormal del hueso, la muerte de las células neuronales, la hepatopatías, los abortos, los nacimientos prematuros o las neuropatías de retina (por ejemplo el glaucoma), etc.
ES99305735T 1998-07-21 1999-07-20 Derivados de omega-cicloaquil-prostaglandina e1. Expired - Lifetime ES2178352T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22105498 1998-07-21

Publications (1)

Publication Number Publication Date
ES2178352T3 true ES2178352T3 (es) 2002-12-16

Family

ID=16760781

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99305735T Expired - Lifetime ES2178352T3 (es) 1998-07-21 1999-07-20 Derivados de omega-cicloaquil-prostaglandina e1.

Country Status (8)

Country Link
US (1) US6235780B1 (es)
EP (1) EP0974580B1 (es)
KR (1) KR100349964B1 (es)
AT (1) ATE218544T1 (es)
DE (1) DE69901658T2 (es)
DK (1) DK0974580T3 (es)
ES (1) ES2178352T3 (es)
PT (1) PT974580E (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006021998A (ja) * 2002-07-18 2006-01-26 Ono Pharmaceut Co Ltd Ｅｐ２アゴニストを有効成分とする月経困難症治療剤
ES2584606T3 (es) 2002-10-10 2016-09-28 Ono Pharmaceutical Co., Ltd. Microesferas que comprenden ONO-1301
JP4662926B2 (ja) * 2003-03-03 2011-03-30 メルク セローノ ソシエテ アノニム プロスタグランジン作動薬としてのγ−ラクタム誘導体
WO2005012232A2 (en) * 2003-07-18 2005-02-10 Applied Research Systems Ars Holding N.V. Hydrazide derivatives as prostaglandin receptors modulators
EP1661580B1 (en) 2003-07-25 2014-01-08 Ono Pharmaceutical Co., Ltd. Remedy for cartilage-related diseases
WO2006043655A1 (ja) 2004-10-22 2006-04-27 Ono Pharmaceutical Co., Ltd. 吸入用医薬組成物
AR056968A1 (es) * 2005-04-11 2007-11-07 Xenon Pharmaceuticals Inc Compuestos espiro-oxindol y composiciones farmacéuticas
AR053710A1 (es) * 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
CN101237885B (zh) 2005-06-03 2011-01-19 小野药品工业株式会社 神经再生和/或保护剂
WO2007079078A1 (en) 2005-12-29 2007-07-12 Bayer Schering Pharma Aktiengesellschaft Diamine derivatives as inhibitors of leukotriene a4 hydrolase
TW200833695A (en) 2006-10-12 2008-08-16 Xenon Pharmaceuticals Inc Use of spiro-oxindole compounds as therapeutic agents
CA2666143A1 (en) * 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
US8183286B2 (en) * 2006-11-16 2012-05-22 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
CA2741024A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
CN103664973B (zh) * 2008-10-17 2017-04-19 泽农医药公司 螺羟吲哚化合物及其作为治疗剂的用途
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
NZ712378A (en) 2009-10-14 2017-05-26 Xenon Pharmaceuticals Inc Synthetic methods for spiro-oxindole compounds
WO2011047173A2 (en) 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
SG183126A1 (en) 2010-02-26 2012-09-27 Xenon Pharmaceuticals Inc Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
CA2869547A1 (en) 2012-04-12 2013-10-17 Xenon Pharmaceuticals Inc. Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
EP2913047B1 (en) 2012-10-29 2019-05-08 Cardio Incorporated Pulmonary disease-specific therapeutic agent
EP2968264A4 (en) 2013-03-14 2016-11-02 Celtaxsys Inc INHIBITORS OF LEUCOTRIENE A4 HYDROLASE
JP6449166B2 (ja) 2013-10-15 2019-01-09 小野薬品工業株式会社 薬剤溶出性ステントグラフト
TW201636017A (zh) 2015-02-05 2016-10-16 梯瓦製藥國際有限責任公司 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法
US10100060B2 (en) 2016-06-16 2018-10-16 Xenon Pharmaceuticals Inc. Asymmetric synthesis of funapide
RU2019119652A (ru) 2016-12-09 2021-01-11 Селтакссис, Инк. Ингибиторы лейкотриен-а4-гидролазы
US10385007B2 (en) 2016-12-09 2019-08-20 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase
US10202334B2 (en) 2016-12-09 2019-02-12 Celtaxsys, Inc. Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
US5204371A (en) 1979-12-10 1993-04-20 Schering Aktiengesellschaft Pharmaceutically active 9-chloroprostaglandins
DE2950027A1 (de) 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
DE3126924A1 (de) 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
JPS5883670A (ja) * 1981-11-13 1983-05-19 Teijin Ltd プロスタグランデインｅ↓１類の製造法
KR950703527A (ko) * 1992-10-20 1995-09-20 후미에 사토 프로스타글란딘 유도체
JP3502952B2 (ja) * 1992-10-20 2004-03-02 大正製薬株式会社 プロスタグランジン誘導体
DE4330177A1 (de) * 1993-08-31 1995-03-02 Schering Ag Neue 9-Chlor-prostaglandin-derivate
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3506485B2 (ja) * 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
JP3162668B2 (ja) * 1997-02-04 2001-05-08 小野薬品工業株式会社 ω−シクロアルキル−プロスタグランジンＥ２誘導体
NO317155B1 (no) * 1997-02-04 2004-08-30 Ono Pharmaceutical Co <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
US6262293B1 (en) * 1997-12-25 2001-07-17 Ono Pharmaceutical Co., Ltd. ω-Cycloalkly-prostaglandin e2 derivatives

Also Published As

Publication number Publication date
KR100349964B1 (ko) 2002-08-22
DE69901658T2 (de) 2002-11-21
PT974580E (pt) 2002-10-31
KR20000011866A (ko) 2000-02-25
EP0974580A1 (en) 2000-01-26
ATE218544T1 (de) 2002-06-15
EP0974580B1 (en) 2002-06-05
US6235780B1 (en) 2001-05-22
DE69901658D1 (de) 2002-07-11
DK0974580T3 (da) 2002-09-30

Similar Documents

Publication Publication Date Title
ES2178352T3 (es) Derivados de omega-cicloaquil-prostaglandina e1.
ATE260254T1 (de) Omega-cycloalkyl-prostaglandin e2 derivate
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
NO994485L (no) Styrt frigivelse av farmasöytiske midler i det fremre kammer i öyet
ES2116950T1 (es) Liberacion controlada de farmacos mioticos y midriaticos en la camara anterior.
AR032840A1 (es) Hoja quirurgica que se usa con un instrumento quirurgico para realizar incisiones en implantes en la esclerotica ocular
ES2193391T3 (es) Antagonistas muscarinicos.
ES2178808T3 (es) Derivados omega-cicloalquil-prostaglandina e2.
ES2075082T3 (es) Derivados de isoquinolina para el tratamiento del glaucoma o hipertension ocular.
AR030816A1 (es) Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos
CR7931A (es) 4-[(2,4-dicloro-5-metroxifenil)amino]-6-alkoxi-3- quinolincarbonitrilos para el tratamiento de lesiones isquemicas
BR9811774A (pt) Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp
BRPI0406879A (pt) Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicos
BR0208353A (pt) Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
BR0208405A (pt) Compostos de diidropirimina substituìdos com ciano e seu uso para tratar doenças
BR0210238A (pt) Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
BR9908301A (pt) Derivados de indol e composições farmacêuticas que compreendem os mesmos
BR9907715A (pt) Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose
BRPI0416469A (pt) agente tropicalizante e métodos para fabricação e uso do mesmo
Erturk et al. The cranio‐orbital foramen, the groove on the lateral wall of the human orbit, and the orbital branch of the middle meningeal artery
AR013273A1 (es) SISTEMA MATERIAL VISCOELÁSTICO GELIFICABLE FORMADO POR DOS PARTES CON POLíMEROS DE GALACTOMANANO Y BORATO.
PE20240657A1 (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y sus usos medicos
ATE171623T1 (de) Natriumhyaluronat enthaltende viskose lösungen zur verwendung als maskierungsmittel in therapeutischer photokeratektomie durch excimer- laser
BR0316775A (pt) Novos análogos de benzopirano e seu uso para o tratamento de glaucoma